GovChime
Notice ID: e6cbe2cc166a4e9e90b2f5f9d5e93401Award NoticeAwardedArchived

Q301 - ClonoSEQ Measurable Residual Disease (MRD) Testing Services

Awarded on December 30, 2025. Full description on SAM.gov.

Awarded tounder 36C25026P0251 (source: SAM.gov award notice)• $243.8K

Overview

Posted
December 30, 2025
Notice type
Award Notice
Set-aside
No Set aside used

Notice details

Office
250-NETWORK CONTRACT OFFICE 10 (36C250)
Place of performance
Cleveland, Ohio, 44106
Last updated
Nov 4, 2026
First published
Last updated on SAM.gov
Award date
Dec 30, 2025
Award amount (SAM.gov award notice)
$243.8K

Identifiers

Solicitation number
36C25026Q0104
Notice ID
e6cbe2cc166a4e9e90b2f5f9d5e93401
Award number (PIID)
36C25026P0251

Description

The Department of Veterans Affairs, Network Contracting Office 10, made an award for a one (1) year firm fixed price (FFP) contract with Adaptive Biotechnologies Corporation, 1165 Eastlake Ave. E, Seattle WA, 98109 to provide Clono-Seq Assay testing services for the Louis Stokes VA Medical Center, Pathology & Laboratory Services (PALMS), 10701 East BLVD., Cleveland, OH 44106.

The point of contact is Thomas Bellamy, Contracting Officer, Network Contracting Office 10 - Thomas.Bellamy@va.gov.

Full description on SAM.gov

Award Overview

Award Number

36C25026P0251

Award Amount (SAM.gov award notice)

$243.8K

Award Date

Dec 30, 2025

Awardee

Awardee UEI

DMW5BNQ331K9

Awardee CAGE Code

5SRQ2

Awardee Address

Seattle, WA 98109, UNITED STATES

Original Solicitation

Notice ID: e6cbe2cc166a4e9e90b2f5f9d5e93401

Posted Date: Dec 30, 2025

Original Response Deadline: Not specified

More From This Vendor

Top 5 most recent

1
  • 36C26026P0708
    ADAPTIVE BIOTECHNOLOGIES CORPORATION
    Department of Veterans AffairsNAICS 621511
    $19.5KSigned Aug 26, 2026

Contacts

Contracting Officer

Primary Contact

Documents

Files (1)

  • 36C25026P0251 Bilaterally Signed.pdf

    13 MBAdded in Award Notice version 6Posted
    Download

Lifecycle

  1. 3
    Version 3Special NoticeArchived

    Q301 - ClonoSEQ Measurable Residual Disease (MRD) Testing Services

    Notice e20d8f5c834840859e63658c02d4d6f5 on SAM.gov

  2. 6
    Version 6Award NoticeArchivedCurrent

    Type changed from Special Notice to Award Notice

    Q301 - ClonoSEQ Measurable Residual Disease (MRD) Testing Services

    Notice e6cbe2cc166a4e9e90b2f5f9d5e93401 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

36C25026Q0104

Archive Date

Jan 14, 2026

Office Address

DAYTON, OH, 45428